NDC 80705-101
ELEPSIA XR 1500 MG
Levetiracetam
ELEPSIA XR 1500 MG is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Tripoint Therapeutics, Llc. The primary component is Levetiracetam.
| Product ID | 80705-101_11662182-a84d-455b-a4ee-5a97cd532b48 |
| NDC | 80705-101 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ELEPSIA XR 1500 MG |
| Generic Name | Levetiracetam |
| Dosage Form | Tablet, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-02-12 |
| Marketing Category | NDA / |
| Application Number | NDA204417 |
| Labeler Name | TRIPOINT THERAPEUTICS, LLC |
| Substance Name | LEVETIRACETAM |
| Active Ingredient Strength | 1500 mg/1 |
| Pharm Classes | Decreased Central Nervous System Disorganized Electrical Activity [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |